Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Mutation Medicine & Life Sciences
Hemochromatosis Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Polymerase Chain Reaction Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Genetic Testing Medicine & Life Sciences
Iron Overload Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1991 2006

Bcr-Abl RNA levels to monitor STI571 leukemia therapy

Press, R.

National Institutes of Health

2/14/031/31/06

Project: Research projectExploratory/Developmental Grants

Leukemia
RNA
Therapeutics
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Oncogene Proteins
Gene Expression
Transcription Factor TFIIB
Trans-Activators
DNA

STRUCTURE AND FUNCTION OF MYB ONCOGENE IN NEURONAL CELLS

Press, R.

National Institutes of Health

7/1/916/30/94

Project: Research projectClinical Investigator Award (CIA)

myb Genes
Neuroblastoma
Brain
Research
Proto-Oncogene Proteins c-myb

Research Output 1982 2017

  • 2206 Citations
  • 26 h-Index
  • 90 Article
  • 5 Chapter
  • 1 Letter
  • 1 Review article
Large Granular Lymphocytic Leukemia
Hematopoiesis
Mutation

CRISPR-Cas9–mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy

Ma, L., Boucher, J. I., Paulsen, J., Matuszewski, S., Eide, C. A., Ou, J., Eickelberg, G., Press, R. D., Zhu, L. J., Druker, B. J., Branford, S., Wolfe, S. A., Jensen, J. D., Schiffer, C. A., Green, M. R. & Bolon, D. N. Oct 31 2017 In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. 11751-11756 6 p.

Research output: Research - peer-reviewArticle

Clustered Regularly Interspaced Short Palindromic Repeats
Drug Resistance
Mutagenesis
Mutation
Pharmaceutical Preparations

DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML

Ma, J., Dunlap, J., Paliga, A., Traer, E., Press, R., Shen, L. & Fan, G. Nov 23 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Research - peer-reviewArticle

Cytogenetics
Mutation
Genes
Cohort Studies
Recurrence
1 Citations

Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices

Arora, R. & Press, R. D. Jan 2 2017 In : Leukemia and Lymphoma. 58, 1, p. 8-16 9 p.

Research output: Research - peer-reviewReview article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Practice Guidelines
RNA
Therapeutics
Protein-Tyrosine Kinases

Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women

Wiedmeier, J. E., Kato, C., Zhang, Z., Lee, H., Dunlap, J., Nutt, E., Rattray, R., McKay, S., Eide, C., Press, R., Mori, M., Druker, B. & Dao, K. H. Sep 1 2016 In : Experimental Hematology. 44, 9, p. 857-865.e5

Research output: Research - peer-reviewArticle

Hematopoiesis
Epigenomics
Mutation
Regulator Genes
Chromatin